These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 200950)

  • 1. Epstein-Barr virus genome carrying lymphocyte subpopulations of human palatine tonsils.
    Veltri RW; Heyl LW; Sprinkle PM
    Proc Soc Exp Biol Med; 1977 Nov; 156(2):282-6. PubMed ID: 200950
    [No Abstract]   [Full Text] [Related]  

  • 2. Epstein-Barr nuclear antigen (EBNA) carrying lymphocytes in human palatine tonsils.
    Veltri RW; McClung JE; Sprinkle PM
    J Gen Virol; 1976 Sep; 32(3):455-60. PubMed ID: 184241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus associated with episodes of recurrent tonsillitis.
    Veltri RW; Sprinkle PM; McClung JE
    Arch Otolaryngol; 1975 Sep; 101(9):552-6. PubMed ID: 169772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral infections associated with recurrent tonsillitis.
    Yamanaka N; Kataura A
    Acta Otolaryngol Suppl; 1984; 416():30-7. PubMed ID: 6099955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Epstein-Barr virus nuclear antigen(s) in different cell lines by radioimmunoelectrophoresis.
    Sculley TB; Spelsberg TC; Pearson GR
    Intervirology; 1984; 22(4):191-200. PubMed ID: 6096291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential appearance of Epstein-Barr virus nuclear and lymphocyte-detected membrane antigens in B cell transformation.
    Moss DJ; Rickinson AB; Wallace LE; Epstein MA
    Nature; 1981 Jun; 291(5817):664-6. PubMed ID: 6264317
    [No Abstract]   [Full Text] [Related]  

  • 7. Epstein-Barr virus gene expression during primary B-lymphocyte infection, in transformed and Burkitt lymphoma-derived cell lines.
    Ernberg I; Kallin B; Dillner J
    Curr Top Microbiol Immunol; 1986; 132():251-6. PubMed ID: 3024918
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro stimulation of lymphocytes of donors seronegative for Epstein-Barr virus by preparations of inactivated Epstein-Barr virus.
    Chang RS; Spina CA
    J Infect Dis; 1976 Jun; 133(6):676-80. PubMed ID: 180190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-mediated immunity against Epstein-Barr virus infected B lymphocytes.
    Klein E; Masucci MG
    Springer Semin Immunopathol; 1982; 5(1):63-73. PubMed ID: 6314570
    [No Abstract]   [Full Text] [Related]  

  • 10. EBV antigens in lymphocytes of patients with exudative tonsillitis, infectious mononucleosis and Hodgkin's disease.
    Veltri RW; McClung JE; Sprinkle PM
    Int J Cancer; 1978 Jun; 21(6):683-7. PubMed ID: 78913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immortalization of human lymphocytes by Epstein-Barr virus.
    Miller G
    Yale J Biol Med; 1982; 55(3-4):305-10. PubMed ID: 6295007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Epstein-Barr virus-coded antigens in lymphocytes isolated from defined patient samples.
    Veltri RW; McClung JE; Sprinkle PM
    IARC Sci Publ (1971); 1978; (24 Pt 2):729-32. PubMed ID: 221395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regions of the EBV genome involved in latency and lymphocyte immortalization.
    Miller G
    Prog Med Virol; 1984; 30():107-28. PubMed ID: 6087408
    [No Abstract]   [Full Text] [Related]  

  • 14. Epstein-Barr virus (EBV) receptors, complement receptors, and EBV infectibility of different lymphocyte fractions of human peripheral blood. II. Epstein-Barr virus studies.
    Einhorn L; Steinitz M; Yefenof E; Ernberg I; Bakacs T; Klein G
    Cell Immunol; 1978 Jan; 35(1):43-58. PubMed ID: 202404
    [No Abstract]   [Full Text] [Related]  

  • 15. [Role of the Epstein-Barr virus in human pathology].
    Rupniewska ZM
    Acta Haematol Pol; 1979; 10(3):183-91. PubMed ID: 228518
    [No Abstract]   [Full Text] [Related]  

  • 16. [In vitro immunization of human lymphocytes with Epstein-Barr virus capsid antigen].
    Kulikov VV; Krivonos AV; Krasheninnikov ME; Borisova OV; Kal'nov SL
    Biull Eksp Biol Med; 1991 Jan; 111(1):62-4. PubMed ID: 1647234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evidence for the persistence of Epstein-Barr-virus in the parotid gland (author's transl)].
    Wilmes E; Wolf H
    Laryngol Rhinol Otol (Stuttg); 1981 Jan; 60(1):7-10. PubMed ID: 6261052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transformation of lymphocytes by Epstein-Barr virus requires only one-fourth of the viral genome.
    Mark W; Sugden B
    Virology; 1982 Oct; 122(2):431-43. PubMed ID: 6293180
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunohistology of Epstein-Barr virus-associated antigens in B cell disorders from immunocompromised individuals.
    Thomas JA; Hotchin NA; Allday MJ; Amlot P; Rose M; Yacoub M; Crawford DH
    Transplantation; 1990 May; 49(5):944-53. PubMed ID: 2159663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus latent gene expression during the initiation of B cell immortalization.
    Allday MJ; Crawford DH; Griffin BE
    J Gen Virol; 1989 Jul; 70 ( Pt 7)():1755-64. PubMed ID: 2544663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.